NASDAQ: NEOG
Neogen Corp Stock

$8.83-0.09 (-1.01%)
Updated Jun 23, 2026
NEOG Price
$8.83
Fair Value Price
-$2.80
Market Cap
$1.92B
52 Week Low
$4.56
52 Week High
$11.43
P/E
-3.15x
P/B
0.91x
P/S
2.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$870.54M
Earnings
-$608.78M
Gross Margin
45.2%
Operating Margin
-64.99%
Profit Margin
-69.9%
Debt to Equity
0.6
Operating Cash Flow
$70M
Beta
0.82
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A

NEOG Overview

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NEOG's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Diagnostic & Research

Industry Rating
C
NEOG
Ranked
#5 of 44

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$25.12A
$104.28B
$164.93B
View Top Diagnostic & Research Stocks

Be the first to know about important NEOG news, forecast changes, insider trades & much more!

NEOG News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NEOG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NEOG ($8.83) is overvalued by 415.05% relative to our estimate of its Fair Value price of -$2.80 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NEOG ($8.83) is not significantly undervalued (415.05%) relative to our estimate of its Fair Value price of -$2.80 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NEOG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NEOG due diligence checks available for Premium users.

Valuation

NEOG fair value

Fair Value of NEOG stock based on Discounted Cash Flow (DCF)

Price
$8.83
Fair Value
-$2.80
Undervalued by
415.05%
NEOG ($8.83) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NEOG ($8.83) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NEOG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NEOG price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-3.15x
Industry
14.53x
Market
7.68x

NEOG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.91x
Industry
3.5x
NEOG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NEOG's financial health

Profit margin

Revenue
$211.2M
Net Income
-$17.0M
Profit Margin
-8%
NEOG's Earnings (EBIT) of -$565.74M... subscribe to Premium to read more.
Interest Coverage Financials
NEOG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.4B
Liabilities
$1.3B
Debt to equity
0.6
NEOG's short-term assets ($590.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NEOG's long-term liabilities ($1.11B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NEOG's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NEOG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$22.7M
Investing
-$11.6M
Financing
$744.0k
NEOG's operating cash flow ($69.54M)... subscribe to Premium to read more.
Debt Coverage Financials

NEOG vs Diagnostic & Research Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NEOGB$1.92B-1.01%-3.15x0.91x
NEOC$1.49B+2.41%-15.09x1.80x
CDNAA$1.30B+0.28%-157.00x4.14x
GRALC$2.62B-1.59%-5.93x1.05x
OPKC$1.10B+2.10%-5.41x0.92x

Neogen Stock FAQ

What is Neogen's quote symbol?

(NASDAQ: NEOG) Neogen trades on the NASDAQ under the ticker symbol NEOG. Neogen stock quotes can also be displayed as NASDAQ: NEOG.

If you're new to stock investing, here's how to buy Neogen stock.

What is the 52 week high and low for Neogen (NASDAQ: NEOG)?

(NASDAQ: NEOG) Neogen's 52-week high was $11.43, and its 52-week low was $4.56. It is currently -22.75% from its 52-week high and 93.64% from its 52-week low.

How much is Neogen stock worth today?

(NASDAQ: NEOG) Neogen currently has 217,673,041 outstanding shares. With Neogen stock trading at $8.83 per share, the total value of Neogen stock (market capitalization) is $1.92B.

Neogen stock was originally listed at a price of $1.01 in Dec 31, 1997. If you had invested in Neogen stock at $1.01, your return over the last 28 years would have been 772.53%, for an annualized return of 8.04% (not including any dividends or dividend reinvestments).

How much is Neogen's stock price per share?

(NASDAQ: NEOG) Neogen stock price per share is $8.83 today (as of Jun 23, 2026).

What is Neogen's Market Cap?

(NASDAQ: NEOG) Neogen's market cap is $1.92B, as of Jun 24, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neogen's market cap is calculated by multiplying NEOG's current stock price of $8.83 by NEOG's total outstanding shares of 217,673,041.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.